Replies to post #20780 on Ariad Pharmaceuticals Inc fka ARIA

[DonShimoda]

50% would not surprise me

Well, "using the more conservative estimate of the 12-month MMR rate for imatinib, the upper bound of the 95th percentile confidence interval...is 34%" so, worse-case, we may need to hit 49%.

[adreamer]

Ariad moving towards a much larger share of the CML market..(and others).....Blowing away my original analysis that put me in the stock....If 113 has similar efficacy we are in for an explosive ride.....Be Patient with Ariad...she's worth waiting for....:0)